Your browser doesn't support javascript.
loading
Ultrasound diagnosis of Terson syndrome as an indicator of extreme severity in neurocritical care patients.
Mesa Galán, L A; Henríquez Recine, M A; Robles Caballero, A; Yus Teruel, S; García Martínez, J R; Egea-Guerrero, J J; Quintana-Diaz, M.
Afiliação
  • Mesa Galán LA; Servicio de Medicina Intensiva, Hospital Universitario La Paz, Madrid, Spain. Electronic address: luismesagalan@gmail.com.
  • Henríquez Recine MA; Servicio de Oftalmología Hospital Universitario La Paz, Madrid, Spain.
  • Robles Caballero A; Servicio de Medicina Intensiva, Hospital Universitario La Paz, Madrid, Spain.
  • Yus Teruel S; Servicio de Medicina Intensiva, Hospital Universitario La Paz, Madrid, Spain.
  • García Martínez JR; Servicio de Oftalmología Hospital Universitario La Paz, Madrid, Spain.
  • Egea-Guerrero JJ; Servicio de Medicina Intensiva, Hospital Universitario Virgen del Rocío, Sevilla, Spain.
  • Quintana-Diaz M; Servicio de Medicina Intensiva, Hospital Universitario La Paz, Madrid, Spain.
Neurologia (Engl Ed) ; 38(3): 181-187, 2023 Apr.
Article em En | MEDLINE | ID: mdl-35305963
INTRODUCTION: Terson syndrome (TS) is defined as any intraocular haemorrhage identified in patients with acute intracranial pathology. TS appears to be associated with clinical severity in patients with subarachnoid haemorrhage (SAH), but the association is yet to be defined in patients with traumatic brain injury (TBI) and intracerebral haemorrhage (ICH). This study aimed to evaluate the diagnostic performance of ocular ultrasound (OU) and its usefulness in clinical practice. MATERIAL AND METHODS: We performed an observational, prospective, single-centre study of neurocritical care patients. We analysed cases and controls, defined according to indirect ophthalmoscopy (IO) and OU findings. We determined the diagnostic characteristics of OU. A multivariate analysis was performed to identify clinically relevant associations. RESULTS: The sample included 91 patients diagnosed with ICH (41.76%), SAH (29.67%), and TBI (28.57%). TS was identified by OU in 8 patients (8.79%) and by IO in 24 (24.37%). The adjusted mortality rate in patients with TS showed an odds ratio (OR) of 4.15 (95% confidence interval [CI], 1.52-11.33). All patients with TS detected by OU presented Glasgow Coma Scale scores < 9, with an elevated risk of needing decompressive craniectomy (OR: 9.84; 95% CI, 1.64-59). OU presented an overall sensitivity of 30.43%, specificity of 98.53%, and diagnostic accuracy of 81.32%. For the detection of vitreous haemorrhage, sensitivity and specificity were 87.5% and 98.5%, respectively. CONCLUSIONS: OU diagnosis of TS identifies extremely critical patients, who may require the highest level of care; TS is an independent risk factor for in-hospital mortality.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Hemorragia Subaracnóidea / Hemorragia Vítrea Tipo de estudo: Diagnostic_studies / Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Hemorragia Subaracnóidea / Hemorragia Vítrea Tipo de estudo: Diagnostic_studies / Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article